Factors Influencing the Intention of Chinese Adults to Recommend COVID-19 Vaccination for Specific or Non-Specific Groups.

Yuxin Pang, Bowen Li, Tongyao Li, Tianan Yang, Jianwei Deng, Wenhao Deng
Author Information
  1. Yuxin Pang: School of Management, Beijing Institute of Technology, Beijing 100081, China. ORCID
  2. Bowen Li: School of Management, Beijing Institute of Technology, Beijing 100081, China. ORCID
  3. Tongyao Li: Macquarie Business School, Macquarie University, Sydney, NSW 2109, Australia. ORCID
  4. Tianan Yang: School of Management, Beijing Institute of Technology, Beijing 100081, China. ORCID
  5. Jianwei Deng: School of Management, Beijing Institute of Technology, Beijing 100081, China. ORCID
  6. Wenhao Deng: School of Management, Beijing Institute of Technology, Beijing 100081, China. ORCID

Abstract

The widespread availability of vaccines has profound implications for sustainable public health. Positive recommendation on vaccination is one of the most effective ways to increase the willingness to vaccinate against COVID-19. This study aims to investigate the factors influencing the intentions to recommend COVID-19 vaccination for specific groups (IRCVSG) and the intentions to recommend COVID-19 vaccination for non-specific groups (IRCVNSG) in China and explore the mediating role of vaccine hesitancy and perception of vaccination information. This study conducted a cross-sectional anonymous online survey of adults (N = 903) in 28 provincial-level administrative regions in China in May 2022. The prevalence of IRCVSG and IRCVNSG was 60.5% and 93.0%, respectively. Health information literacy has a significant direct and indirect impact on IRCVSG through safety hesitancy and the perceived adequacy and usefulness of vaccination information. The relationship between health information literacy and IRCVNSG is entirely mediated via hesitation about the effectiveness and perceived usefulness of vaccination information. Special attention should be paid to the safety hesitation of COVID-19 vaccination for specific groups. This study tests these effects from both theoretical and practical perspectives, helping to address barriers to promoting the vaccination of specific groups for COVID-19 in clinical practice, improving health and sustainability.

Keywords

References

  1. Indian J Psychol Med. 2020 Aug 27;42(5):478-481 [PMID: 33414597]
  2. Hum Vaccin Immunother. 2022 Nov 30;18(6):2090776 [PMID: 35763311]
  3. Health Econ. 2017 Dec;26 Suppl 3:66-75 [PMID: 29285869]
  4. Vaccine. 2020 Sep 29;38(42):6500-6507 [PMID: 32863069]
  5. J Public Health (Oxf). 2021 Dec 10;43(4):695-702 [PMID: 33693905]
  6. Vaccines (Basel). 2022 Mar 29;10(4): [PMID: 35455275]
  7. J Med Internet Res. 2021 May 6;23(5):e25600 [PMID: 33822734]
  8. Epidemiol Infect. 2021 Apr 23;149:e158 [PMID: 33888165]
  9. Clin Nurs Res. 2022 Jul;31(6):981-990 [PMID: 35484917]
  10. Prev Med. 2021 Apr;145:106408 [PMID: 33388335]
  11. J Behav Med. 2023 Apr;46(1-2):15-24 [PMID: 35032254]
  12. Int J Nurs Stud. 2009 Sep;46(9):1219-35 [PMID: 19349047]
  13. Hum Vaccin Immunother. 2019;15(7-8):1607-1614 [PMID: 30240333]
  14. Front Microbiol. 2020 Jul 14;11:1526 [PMID: 32760367]
  15. Pediatrics. 2009 Nov;124(5):e809-16 [PMID: 19822592]
  16. J Adv Nurs. 2011 Apr;67(4):829-40 [PMID: 21077933]
  17. Int J Environ Res Public Health. 2021 Jul 30;18(15): [PMID: 34360384]
  18. World Med Health Policy. 2020 Dec;12(4):443-453 [PMID: 33362943]
  19. PLoS One. 2022 Mar 23;17(3):e0265496 [PMID: 35320309]
  20. Vaccine. 2018 Nov 26;36(49):7556-7561 [PMID: 30389192]
  21. Front Public Health. 2021 Oct 28;9:658107 [PMID: 34778159]
  22. Vaccine. 2016 Dec 20;34(52):6681-6690 [PMID: 27876197]
  23. Hum Vaccin Immunother. 2014;10(7):2130-5 [PMID: 25424830]
  24. Prev Med. 2022 Aug;161:107138 [PMID: 35809825]
  25. Cancer Cell. 2022 Jan 10;40(1):3-5 [PMID: 34838186]
  26. Vaccine. 2019 Oct 16;37(44):6750-6759 [PMID: 31558328]
  27. PLoS One. 2021 Nov 15;16(11):e0260049 [PMID: 34780555]
  28. Vaccines (Basel). 2022 May 04;10(5): [PMID: 35632477]
  29. Ambul Pediatr. 2007 Sep-Oct;7(5):367-73 [PMID: 17870645]
  30. Hum Vaccin Immunother. 2020 May 3;16(5):1004-1006 [PMID: 32401681]
  31. Curr Psychol. 2022;41(11):8147-8156 [PMID: 34312580]
  32. Vaccine. 2012 Feb 1;30(6):1149-53 [PMID: 22178729]
  33. Gene Rep. 2021 Dec;25:101417 [PMID: 34778602]
  34. Lancet Child Adolesc Health. 2022 Jul;6(7):459-465 [PMID: 35526537]
  35. Arch Razi Inst. 2021 Dec 30;76(6):1823-1830 [PMID: 35546989]
  36. Fam Pract. 2003 Apr;20(2):162-6 [PMID: 12651790]
  37. BJOG. 2022 Jul;129(8):1342-1351 [PMID: 35104382]
  38. Vaccines (Basel). 2021 Jan 07;9(1): [PMID: 33430191]
  39. Front Public Health. 2022 Jan 27;9:754904 [PMID: 35155334]
  40. J Health Commun. 2020 Sep 1;25(9):727-735 [PMID: 33186091]
  41. Hum Vaccin Immunother. 2019;15(7-8):1465-1475 [PMID: 30779682]
  42. J Med Internet Res. 2006 Nov 14;8(4):e27 [PMID: 17213046]

Grants

  1. 71974011, 72174022, 71972012/National Natural Science Foundation of China

Word Cloud

Created with Highcharts 10.0.0vaccinationCOVID-19informationhealthgroupsstudyspecificIRCVSGIRCVNSGChinahesitancyliteracyintentionsrecommendsafetyperceivedusefulnesshesitationwidespreadavailabilityvaccinesprofoundimplicationssustainablepublicPositiverecommendationoneeffectivewaysincreasewillingnessvaccinateaimsinvestigatefactorsinfluencingnon-specificexploremediatingrolevaccineperceptionconductedcross-sectionalanonymousonlinesurveyadultsN=90328provincial-leveladministrativeregionsMay2022prevalence605%930%respectivelyHealthsignificantdirectindirectimpactadequacyrelationshipentirelymediatedviaeffectivenessSpecialattentionpaidtestseffectstheoreticalpracticalperspectiveshelpingaddressbarrierspromotingclinicalpracticeimprovingsustainabilityFactorsInfluencingIntentionChineseAdultsRecommendVaccinationSpecificNon-SpecificGroups

Similar Articles

Cited By